CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 4 Exercise or conversion SVP, Corp Dev., Alkermes, Inc. acquired 5,523 shares (option exercise)
- 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 368 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 1,029 shares (to pay taxes)
- 4 Gift SVP, CLO, Alkermes, Inc. gave 1,000 shares (gift)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director and CEO, Alkermes plc sold 75,000 shares at $15.00 ($1,125,233)
- 4 Exercise or conversion SVP, Alks Inc; CFO ALKS acquired 21,983 shares (option exercise)
- 4 Open-market sale SVP Finance & CAO, Alks Inc. sold 6,250 shares at $15.39 ($96,193)
- 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 18,000 shares at $15.75 ($283,469)
- 4 Open-market sale Director and CEO, Alkermes plc sold 50,000 shares at $14.63 ($731,265)
- 4 Open-market sale SVP, Corp Dev., Alkermes, Inc. sold 25,000 shares at $14.06 ($351,425)
Page 20 of 67 · 1,323 filings